CRISIS GOTOSA TRATAMIENTO PDF

June 18, 2020 0 Comments

La gota es una forma dolorosa y potencialmente incapacitante de artritis que ha Las opciones de tratamiento dependen de la función renal, otros problemas. TRATAMIENTO GOTA. RC. Roberto Calvo. Updated 29 October Transcript. ARTRITIS AGUDA (III). ALOPURINOL. Primaria: Aumento producción (%). Consecuencias del alcoholismo: el hígado graso. La artritis gotosa. Diagnóstico. Tratamiento. CH3CH2OH + H2O2 → CH3CHO +.

Author: Kajibei Jugor
Country: Australia
Language: English (Spanish)
Genre: Photos
Published (Last): 4 April 2017
Pages: 209
PDF File Size: 1.54 Mb
ePub File Size: 14.6 Mb
ISBN: 797-7-92801-147-7
Downloads: 4958
Price: Free* [*Free Regsitration Required]
Uploader: Zulkidal

Consensus document for the detection and management of chronic kidney disease. Contiene los siguientes aspectos: Seguimiento del paciente, actitudes y objetivos por especialidad.

Actitudes, estilo de vida y tratamiento: Tratamiento paliativo gotoss la uremia terminal. Ten scientific societies involved in the management of kidney patients agreed to gotoda the CKD consensus document. The current version is an abridged edition of the detailed general document, which can be consulted on the webpages of each signatory society. It includes the following aspects: CKD definition, epidemiology and risk factors and criteria on diagnosis, assessment and staging of CKD, albuminuria and glomerular filtration estimation.

Progression factors and concept. Criteria for referral to Nephrology. Patient follow-up, attitudes and objectives by specialty. Detection of cardiovascular damage.

TRATAMIENTO GOTA by Roberto Calvo on Prezi

Attitudes, lifestyle and treatment: Coordinated follow-up by Primary Care – other specialties – Nephrology. Management of renal replacement therapy, yratamiento, peritoneal dialysis and renal transplantation patients. Palliative treatment of terminal uraemia. We hope that this document will be very useful in the multidisciplinary management of CKD patients, in view of the updated recommendations.

Este documento de consenso surge de la necesidad de revisar y actualizar el anterior de S. Modification of Diet in Renal Disease.

LA ARTRITIS GOTOSA Y EL ALCOHOLISMO by P. ía on Prezi

Kidney Disease Improving Global Outcomes. Valorar previamente comorbilidades asociadas. En cualquier caso, es necesario individualizar estos criterios generales. Evitar hipotensiones en pacientes de edad avanzada y enfermedad ateromatosa importante.

El consumo diario de sal ha de ser menor de 6g equivale a 2,4g de sodio. A pesar de ello, cuando se instaure su tratamiento se debe iniciar con una dosis baja 0,5mg. La metformina se elimina principalmente por la orina sin metabolizarse.

  BOULEZ DOUZE NOTATIONS PDF

Linagliptina no precisa ajuste de dosis en todos los estadios de la ERC. La experiencia con liraglutida y exenatida en este campo es cirsis escasa. Los resultados en estadios 4 y 5 o en HD no son tan claros 49, La dieta es el determinante principal de los niveles de colesterol.

Fluvastatina, pravastatina, pitavastatina y rosuvastatina tienen menos probabilidad de interaccionar. No obstante, dada la escasa evidencia del beneficio cardiovascular del tratamiento de crisiis hipertrigliceridemia con fibratos y sus potenciales efectos secundarios, no se recomienda el tratamiento con fibratos en la ERC, especialmente cuando se asocien a estatinas.

Colchicina

No se requiere ajuste de dosis en insuficiencia renal. Metabolismo del hierro requerido previo al inicio de tratamiento con agentes estimulantes de la eritropoyesis.

El control debe realizarse cada meses. Posibles efectos adversos secundarios al tratamiento con agentes estimulantes de la eritropoyesis. En el estadio 4 se aconseja incluso mantener la PTH en valores ligeramente superiores a la normalidad. Se administran con las comidas. Entre los quelantes sin calcio ni aluminio, destacan el sevelamer y el carbonato de lantano. Es lo que llamamos trasplante renal anticipado. Claves para el manejo del paciente portador de un trasplante renal.

Claves para el seguimiento de la uremia terminal en domicilio. Prevalence of chronic renal disease in Spain: Am J Kidney Dis ;39 Suppl 1: National Collaborating Centre for Chronic Conditions. Royal College of Physicians; Kidney Int Suppl ;3: Conceptual model of CKD: Am J Kidney Dis ;53 3 Suppl 3: A more accurate method to estimate glomerular filtration rate from serum creatinine: Ann Intern Med ; A new equation to estimate glomerular filtration rate.

Am J Kidney Dis ; Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. Current use of equations for estimating glomerular filtration rate in Spanish laboratories. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med ; Prediction of creatinine clearance from serum creatinine. Estimating renal function for drug dosing decisions.

Clin Biochem Rev ; Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Levey A, Coresh J. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

  EXTRON P 2 DA2XI PDF

J Clin Invest ; J Am Soc Nephrol ; The effects of dietary protein restriction an blood pressure control on the progression of chronic renal disease.

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. Intensive blood glucose control and vascular outcomes in patients with type trqtamiento diabetes. Cardiovascular disease and subsequent kidney disease. Arch Intern Med ; Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.

Nephrol Dial Transplant ; Treatment of metabolic syndrome slows progression of diabetic nephropathy. Metab Syndr Relat Disord ;9: The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health ;50 3: End-stage renal disease and non-narcotic analgesics: Br J Clin Pharmacol ;30 5: A systematic review crksis patient and health system characteristics associated with late referral in chronic kidney disease. Nephrol Dial Transplant ;27 6: Patient and provider determinants of nephrology referral in older adults with severe chronic kidney disease: Tejedor A, de las Cuevas X.

Nefrologia ;28 Suppl 3: Kidney Int ;2 Suppl: Influence of contrast media on single nephron glomerular filtration rate in rat kidney.

A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

Overweight, obesity and intentional weight loss in chronic kidney disease: Int J Obes Lond ;36 Ann Intern Med ; 8: Assessing glycemic control in patients with diabetes and end-stage renal failure.

Glycosylated haemoglobin in renal crsis. Effects of azotemia on results of the boronate-agarose affinity method and in exchange methods for glycated hemoglobin.

Wettre S, Lundberg M. Kinetics of glycosylated hemoglobin in uremia determined on ion-exchange and affinity chromatography. Glycosylated haemoglobin in uraemia. Long-term glycemic control measurements in gptosa patients receiving hemodialysis. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.